Skip to main content
. 2020 Oct 9;41(12):1671–1681. doi: 10.1093/carcin/bgaa105

Figure 3.

Figure 3.

Disease-specific survival curves for ≤500 versus >500 CD8 TILs per mm2 and ≤400 versus >400 CD20 TILs per mm2 and their combination in (A, D and G) all patients; (B, E and H) the LUSC subgroup; (C, F and I) the LUAD subgroup.